Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study.

BACKGROUND Middle molecules (MMs) and protein-bound solutes are poorly removed by conventional hemodialysis (HD). Hemodiafiltration (HDF) combines convection and diffusion in a single therapy and has been shown to be superior for the elimination of several small and larger retention molecules. Information on the elimination of protein-bound solutes during convective strategies is scarce. The primary aim of this randomized crossover study is to evaluate the influence of internal filtration, postdilution HDF, and predilution HDF on removal of the protein-bound solute p-cresol. METHODS Fourteen stable patients on regular thrice-weekly medium-flux HD therapy were assigned to 5 treatment periods of 2 weeks each for: HD with HF80(S); HD with FX80; postdilution HDF, 20 L, with FX80; predilution HDF, 20 L, with FX80; and predilution HDF, 60 L, with FX80 (all dialyzers from Fresenius Medical Care, Bad Homburg, Germany). RESULTS As for the water-soluble solutes, elimination of p-cresol was better during HDF and increased with greater filtration volumes. Removal of beta2-microglobulin (beta2m) also was enhanced during HDF. However, the positive effect of convection was offset when high predilution substitution volumes were applied, probably as a result of dilution. Within each dialytic approach, removal of the MM beta2m and the protein-bound solute p-cresol was significantly less than that of the water-soluble molecules urea nitrogen and creatinine. CONCLUSION Our data indicate that convection can provide superior protein-bound solute removal compared with high-flux HD. Our findings also suggest that better elimination of the unbound fraction is the most plausible underlying mechanism.

[1]  P. Lim,et al.  Evaluation of Pre- and Postdilutional On-Line Hemodiafiltration Adequacy by Partial Dialysate Quantification and On-Line Urea Monitor , 1999, Blood Purification.

[2]  Raymond Vanholder,et al.  Review on uremic toxins: classification, concentration, and interindividual variability. , 2003, Kidney international.

[3]  Willy Lornoy,et al.  Remarkable Removal of Beta-2-Microglobulin by On-Line Hemodiafiltration , 1998, American Journal of Nephrology.

[4]  A. Enomoto,et al.  Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. , 2002, Journal of the American Society of Nephrology : JASN.

[5]  C. Ronco,et al.  Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. , 1996, Kidney international.

[6]  S. Sprague,et al.  The Pathogenesis of β2‐Microglobulin–Induced Bone Lesions in Dialysis‐Related Amyloidosis , 2001, Seminars in dialysis.

[7]  W Samtleben,et al.  A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. , 2000, Journal of the American Society of Nephrology : JASN.

[8]  K. Verbeke,et al.  Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. , 2003, Kidney international.

[9]  R. Vanholder,et al.  Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  Jürgen Floege,et al.  β2-Microglobulin–derived amyloidosis: An update , 2001 .

[11]  K. Renggli,et al.  Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients. , 1999, Clinical nephrology.

[12]  R. Vanholder,et al.  Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  K. Maeda,et al.  Efficient removal of albumin-bound furancarboxylic acid, an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis. , 1990, Nephron.

[14]  Francesco Locatelli,et al.  Dose of dialysis, convection and haemodialysis patients outcome--what the HEMO study doesn't tell us: the European viewpoint. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  Z. Massy,et al.  Uremic Toxicity: Present State of the Art , 2001, The International journal of artificial organs.

[16]  N. Levin,et al.  Reflections on the HEMO study: the American viewpoint. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  J. Billiouw,et al.  On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  R. Vanholder,et al.  Toxicity of free p-cresol: a prospective and cross-sectional analysis. , 2003, Clinical chemistry.

[19]  F. Ding,et al.  Online hemodiafiltration versus acetate-free biofiltration: a prospective crossover study. , 2002, Artificial organs.

[20]  Johanna T Dwyer,et al.  Effect of dialysis dose and membrane flux in maintenance hemodialysis. , 2002, The New England journal of medicine.

[21]  S Mandolfo,et al.  Impact of Blood and Dialysate Flow and Surface on Performance of New Polysulfone Hemodialysis Dialyzers , 2003, The International journal of artificial organs.

[22]  J. Leypoldt,et al.  Solute fluxes in different treatment modalities. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  B. Molitoris,et al.  Plasma protein adsorption to highly permeable hemodialysis membranes. , 1995, Kidney international.

[24]  M. Custaud,et al.  Albumin Loss in On-Line Hemodiafiltration , 2002, The International journal of artificial organs.

[25]  T. Miyazaki,et al.  The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. , 1997, Kidney international. Supplement.

[26]  R Vanholder,et al.  Protein-bound uremic solutes: the forgotten toxins. , 2001, Kidney international. Supplement.

[27]  C Ronco,et al.  Nanoscale Modulation of the Pore Dimensions, Size Distribution and Structure of a new Polysulfone-Based High-Flux Dialysis Membrane , 2001, The International journal of artificial organs.

[28]  R. Vanholder,et al.  Pathophysiologic effects of uremic retention solutes. , 1999, Journal of the American Society of Nephrology : JASN.

[29]  R. Vanholder,et al.  A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[30]  Chiu-Ching Huang,et al.  Long-Term On-Line Hemodiafiltration Reduces Predialysis Beta-2-Microglobulin Levels in Chronic Hemodialysis Patients , 2001, Blood Purification.

[31]  B. Maldague,et al.  Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis. , 1991, Kidney international.

[32]  N W Levin,et al.  Effects of a reduced inner diameter of hollow fibers in hemodialyzers. , 2000, Kidney international.

[33]  T. Miyazaki,et al.  Efficient removal of albumin-bound furancarboxylic acid by protein-leaking hemodialysis. , 1995, American journal of nephrology.

[34]  D. Walb,et al.  Transmembranous Transport and Adsorption of Beta-2-microglobulin during Hemodialysis using Polysulfone, polyacrylonitrile, polymethylmethacrylate and Cuprammonium Rayon Membranes , 1989, The International journal of artificial organs.

[35]  C. Ronco,et al.  Hemodialyzer: from macro-design to membrane nanostructure; the case of the FX-class of hemodialyzers. , 2002, Kidney international. Supplement.

[36]  T. Niwa,et al.  Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure. , 1996, Seminars in nephrology.